In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

One of the more difficult decisions for patients with poorly controlled type 2 diabetes, as well as for their clinicians, is ...

Tarlatamab improved PFS and OS over chemotherapy as second-line treatment in patients with SCLC in the phase 3 DeLLphi-304 trial.

A team at the Technical University of Munich has created a high-tech robotic tool designed to step in during critical moments, like when someone’s lung fails. The device is an advanced robot arm ...